Funding Cuts Leave Ebola Research Network Idle During Outbreak
NIH-backed Centers for Research in Emerging Infectious Diseases (CREID) received about $82 million over five years but were halted in 2025 after the Trump administration cut funding amid Covid-conspiracy theories; as the Ebola outbreak in the DRC grows, researchers in the U.S. are unable to help due to the funding gap, leaving on-the-ground testing, reagents, and genomic sequencing efforts unused—despite CREID’s past role in rapid detection and outbreak response across Africa.